03:24 AM EST, 02/18/2025 (MT Newswires) -- Stephen A Sherwin, Director, on February 13, 2025, sold 13,831 shares in Neurocrine Biosciences ( NBIX ) for $1,613,923. Following the Form 4 filing with the SEC, Sherwin has control over a total of 10,673 common shares of the company, with 10,673 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/914475/000091447525000071/xslF345X05/wk-form4_1739576962.xml